Diagonal Bio AB Second Quarter Report (Q2 2024)
“In the second quarter of 2024, we have made advancements, particularly within the equine healthcare sector (horse veterinary clinics) where our connections and the interest in our Point-of-Care instrument continue to deepen.”Summary of Q1 report 2024 2024-04-01 — 2024-06-30 (April — June 2024) ● Net sales amounted to 0 KSEK (0 KSEK), capitalised development contributed with 284 KSEK (911 KSEK),and other operating income amounted to 0 KSEK (4 KSEK). ● Operating profit amounted to -3 118 KSEK (-2 798 KSEK). ● Operating profit per net weighted average
Read original